The abundance of activated cells (amoeboid morphological feature) in NMO rats without the antibody treatment (Fig. 3B) was much more than that in the NMO rats treated with anti-RGMa mAb (Fig. 3C,D). This evidence concerns the gene RGMA and neuromyelitis optica.